fluoxetine has been researched along with Cancer of Colon in 11 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this study, we investigated the effects of fluoxetine, desipramine, and mirtazapine on the liver metastasis of murine C26 colon carcinoma (cc)." | 8.31 | Stimulatory effect of fluoxetine and desipramine, but not mirtazapine on C26 colon carcinoma hepatic metastases formation: association with cytokines. ( Arteta, B; Curzytek, K; Grygier, B; Kubera, M; Maes, M; Malicki, S, 2023) |
| "Treatment with fluoxetine had no effect on tumor growth, muscle wasting, fatigue behavior, or cytokine expression in the brain." | 5.42 | Fluoxetine prevents the development of depressive-like behavior in a mouse model of cancer related fatigue. ( Bicer, S; Devine, R; Godbout, JP; Jing, R; McCarthy, DO; Norden, DM; Reiser, PJ; Wold, LE, 2015) |
| "Pretreatment with fluoxetine attenuated the increased IκB kinase (IKK) and IκBα phosphorylation induced by TNF-α." | 5.37 | Fluoxetine inhibits NF-κB signaling in intestinal epithelial cells and ameliorates experimental colitis and colitis-associated colon cancer in mice. ( Jung, HC; Kim, IK; Kim, JM; Kim, JS; Kim, N; Koh, SJ; Song, IS, 2011) |
| " In this study, we investigated the effects of fluoxetine, desipramine, and mirtazapine on the liver metastasis of murine C26 colon carcinoma (cc)." | 4.31 | Stimulatory effect of fluoxetine and desipramine, but not mirtazapine on C26 colon carcinoma hepatic metastases formation: association with cytokines. ( Arteta, B; Curzytek, K; Grygier, B; Kubera, M; Maes, M; Malicki, S, 2023) |
| " We demonstrated the combinations of doxorubicin (DOX) + artesunate, DOX + chloroquine, paclitaxel (PTX) + fluoxetine, PTX + fluphenazine, and PTX + benztropine induce significant cytotoxicity in Michigan Cancer Foundation-7 (MCF-7) breast cancer cells." | 4.12 | Combination of Antimalarial and CNS Drugs with Antineoplastic Agents in MCF-7 Breast and HT-29 Colon Cancer Cells: Biosafety Evaluation and Mechanism of Action. ( Duarte, D; Nunes, M; Ricardo, S; Vale, N, 2022) |
| "Treatment with fluoxetine had no effect on tumor growth, muscle wasting, fatigue behavior, or cytokine expression in the brain." | 1.42 | Fluoxetine prevents the development of depressive-like behavior in a mouse model of cancer related fatigue. ( Bicer, S; Devine, R; Godbout, JP; Jing, R; McCarthy, DO; Norden, DM; Reiser, PJ; Wold, LE, 2015) |
| "Colon cancer is one of the most common tumors in the human population." | 1.42 | Oncostatic effects of fluoxetine in experimental colon cancer models. ( Alho, EJ; Friedrich, M; Garcia, SB; Gasser, M; Heinsen, H; Heinze, KG; Kannen, V; Mönch, R; Scholz, CJ; Silva, WA; Stopper, H; Waaga-Gasser, AM, 2015) |
| "Pretreatment with fluoxetine attenuated the increased IκB kinase (IKK) and IκBα phosphorylation induced by TNF-α." | 1.37 | Fluoxetine inhibits NF-κB signaling in intestinal epithelial cells and ameliorates experimental colitis and colitis-associated colon cancer in mice. ( Jung, HC; Kim, IK; Kim, JM; Kim, JS; Kim, N; Koh, SJ; Song, IS, 2011) |
| "Fluoxetine (FLX) is a drug commonly used as antidepressant." | 1.37 | Fluoxetine induces preventive and complex effects against colon cancer development in epithelial and stromal areas in rats. ( Bonato, PS; Brandão, ML; Carvalho, MC; Ferreira, FR; Garcia, SB; Jabor, VA; Kannen, V; Marini, T; Silva, WA; Turatti, A; Zanette, DL, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Duarte, D | 1 |
| Nunes, M | 1 |
| Ricardo, S | 1 |
| Vale, N | 1 |
| Kubera, M | 1 |
| Arteta, B | 1 |
| Grygier, B | 1 |
| Curzytek, K | 1 |
| Malicki, S | 1 |
| Maes, M | 1 |
| Hassan, ESG | 1 |
| Hassanein, NM | 1 |
| Sayed Ahmed, HM | 1 |
| Norden, DM | 1 |
| Devine, R | 1 |
| Bicer, S | 1 |
| Jing, R | 1 |
| Reiser, PJ | 1 |
| Wold, LE | 1 |
| Godbout, JP | 1 |
| McCarthy, DO | 1 |
| Kannen, V | 3 |
| Garcia, SB | 3 |
| Silva, WA | 3 |
| Gasser, M | 1 |
| Mönch, R | 1 |
| Alho, EJ | 1 |
| Heinsen, H | 1 |
| Scholz, CJ | 1 |
| Friedrich, M | 1 |
| Heinze, KG | 1 |
| Waaga-Gasser, AM | 2 |
| Stopper, H | 2 |
| Argov, M | 1 |
| Kashi, R | 1 |
| Peer, D | 1 |
| Margalit, R | 1 |
| Koh, SJ | 1 |
| Kim, JM | 1 |
| Kim, IK | 1 |
| Kim, N | 1 |
| Jung, HC | 1 |
| Song, IS | 1 |
| Kim, JS | 1 |
| Marini, T | 1 |
| Turatti, A | 1 |
| Carvalho, MC | 1 |
| Brandão, ML | 1 |
| Jabor, VA | 1 |
| Bonato, PS | 1 |
| Ferreira, FR | 1 |
| Zanette, DL | 2 |
| Hintzsche, H | 1 |
| Parish, JM | 1 |
| Tutton, PJ | 1 |
| Barkla, DH | 1 |
11 other studies available for fluoxetine and Cancer of Colon
| Article | Year |
|---|---|
Combination of Antimalarial and CNS Drugs with Antineoplastic Agents in MCF-7 Breast and HT-29 Colon Cancer Cells: Biosafety Evaluation and Mechanism of Action.
Topics: Adenosine Diphosphate; Antimalarials; Antineoplastic Agents; Artesunate; ATP Binding Cassette Transp | 2022 |
Stimulatory effect of fluoxetine and desipramine, but not mirtazapine on C26 colon carcinoma hepatic metastases formation: association with cytokines.
Topics: Animals; Antidepressive Agents; Carcinoma; Colonic Neoplasms; Cytokines; Desipramine; Fluoxetine; Li | 2023 |
Probing the chemoprevention potential of the antidepressant fluoxetine combined with epigallocatechin gallate or kaempferol in rats with induced early stage colon carcinogenesis.
Topics: Animals; Anti-Inflammatory Agents; Antidepressive Agents; Antioxidants; Apoptosis; Catechin; Cell Pr | 2021 |
Fluoxetine prevents the development of depressive-like behavior in a mouse model of cancer related fatigue.
Topics: Adenocarcinoma; Administration, Oral; Animals; Antidepressive Agents, Second-Generation; Brain; Colo | 2015 |
Oncostatic effects of fluoxetine in experimental colon cancer models.
Topics: Animals; Caco-2 Cells; Cell Hypoxia; Colonic Neoplasms; Fluoxetine; G1 Phase; Humans; Mice; Mice, In | 2015 |
Treatment of resistant human colon cancer xenografts by a fluoxetine-doxorubicin combination enhances therapeutic responses comparable to an aggressive bevacizumab regimen.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemothe | 2009 |
Fluoxetine inhibits NF-κB signaling in intestinal epithelial cells and ameliorates experimental colitis and colitis-associated colon cancer in mice.
Topics: Animals; Cell Line; Cell Transformation, Neoplastic; Colitis; Colonic Neoplasms; Fluoxetine; Humans; | 2011 |
Fluoxetine induces preventive and complex effects against colon cancer development in epithelial and stromal areas in rats.
Topics: Animals; Cell Proliferation; Colon; Colonic Neoplasms; Cyclooxygenase 2; Fluoxetine; Male; Precancer | 2011 |
Antiproliferative effects of fluoxetine on colon cancer cells and in a colonic carcinogen mouse model.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Carcinogens; Cell Cycle; Cell Proliferation; Cell Trans | 2012 |
"I can't sleep at night" an unusual case of insomnia.
Topics: Aged; Anemia, Iron-Deficiency; Blood Transfusion; Colonic Neoplasms; Combined Modality Therapy; Cont | 2005 |
Influence of inhibitors of serotonin uptake on intestinal epithelium and colorectal carcinomas.
Topics: Animals; Cell Division; Cell Line; Citalopram; Colonic Neoplasms; Epithelium; Fluoxetine; Intestines | 1982 |